⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Pharmaselect International Beteiligungs GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Pharmaselect International Beteiligungs GmbH
↗Vienna, Austria
Pharmaselect is a privately owned, Vienna-based pharmaceutical company founded in 2000. The company focuses on acquiring and marketing established originator products from larger pharmaceutical firms, as well as developing and selling its own generic and complementary products.
Their business model emphasizes a mix of prescription (Rx) and over-the-counter (OTC) medicines, with core therapeutic expertise in ophthalmology, rheumatology, neurology, and hospital-based niche products. The company maintains a strong presence in Central-Eastern Europe (CEE) and CIS countries, operating through a network of subsidiaries.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:1-50
Founded:2000
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Natural substances
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Pharmaselect Handels GmbH
COMPETITION
Position:Niche Player
LINKS
Website:pharmaselect.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Pharmaselect International Beteiligungs GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.